Form 8-K - Current report:
SEC Accession No. 0001213900-24-057575
Filing Date
2024-07-01
Accepted
2024-07-01 08:30:14
Documents
13
Period of Report
2024-06-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208739-8k_lucy.htm   iXBRL 8-K 25271
  Complete submission text file 0001213900-24-057575.txt   198912

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lsdi-20240627.xsd EX-101.SCH 3033
3 XBRL LABEL FILE lsdi-20240627_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lsdi-20240627_pre.xml EX-101.PRE 22371
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0208739-8k_lucy_htm.xml XML 3680
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41616 | Film No.: 241088287
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)